cytarabine has been researched along with Extranodal NK-T-Cell Lymphoma in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 6 (75.00) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Q; Dong, M; Wu, S; Yang, Z; Zhang, M; Zhang, X | 1 |
| Gong, Y; Jin, H; Ma, X; Pang, F; Pu, W; Wang, Y; Yang, P; Zeng, H | 1 |
| Díaz-Llopis, M; España-Gregori, E; Hernández-Martínez, P; Hervás-Ontiveros, A; Vera-Sempere, FJ | 1 |
| Itani, K; Miyazaki, Y; Nagamatsu, K; Otsuka, E; Saburi, M; Saburi, Y; Urabe, S | 1 |
| Antosikova, A; Bosq, J; Carde, P; Chamseddine, AN; Danu, A; Dartigues, P; De Botton, S; Ferme, C; Ghez, D; Girinsky, T; Koscielny, S; Lazarovici, J; Mazeron, R; Michot, JM; Minard, V; Ribrag, V; Willekens, C | 1 |
| Chihara, D; Dang, NH; Fanale, MA; Fayad, LE; Fowler, NH; Hagemeister, FB; Kwak, LW; Loghavi, S; McLaughlin, P; Medeiros, LJ; Miranda, RN; Neelapu, SS; Oki, Y; Pro, B; Rodriguez, MA; Romaguera, JE; Samaniego, F; Wang, M; Younes, A | 1 |
| Carpten, JD; Cortes, D; Craig, D; Kirov, I; McEachron, TA; Sassoon, A; Sender, LS; Wungwattana, M; Zabokrtsky, KB | 1 |
| McMillan, A; O'Connor, S; Wills, AJ | 1 |
1 trial(s) available for cytarabine and Extranodal NK-T-Cell Lymphoma
| Article | Year |
|---|---|
Phase II study of HCVIDD/MA in patients with newly diagnosed peripheral T-cell lymphoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Cyclophosphamide; Cytarabine; Dexamethasone; Disease-Free Survival; Doxorubicin; Drug Administration Schedule; Female; Humans; Kaplan-Meier Estimate; Lymphoma, Extranodal NK-T-Cell; Lymphoma, T-Cell, Peripheral; Male; Medication Adherence; Methotrexate; Middle Aged; Polyethylene Glycols; Remission Induction; Treatment Outcome; Vincristine; Young Adult | 2015 |
7 other study(ies) available for cytarabine and Extranodal NK-T-Cell Lymphoma
| Article | Year |
|---|---|
sATP‑binding cassette subfamily G member 2 enhances the multidrug resistance properties of human nasal natural killer/T cell lymphoma side population cells.
Topics: Antineoplastic Agents; Asparaginase; ATP Binding Cassette Transporter, Subfamily G, Member 2; Cell Line, Tumor; Cell Proliferation; Cytarabine; Deoxycytidine; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Gemcitabine; Gene Expression Regulation, Neoplastic; Humans; Lymphoma, Extranodal NK-T-Cell; Neoplasm Proteins | 2020 |
Quantitative proteomics of CSF reveals potential predicted biomarkers for extranodal NK-/T-cell lymphoma of nasal-type with ethmoidal sinus metastasis.
Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Cerebrospinal Fluid; China; Cytarabine; Ethmoid Sinus; Female; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Lymphoma, Extranodal NK-T-Cell; Male; Mass Spectrometry; Middle Aged; Neoplasm Metastasis; Nose Neoplasms; Prognosis; Proteomics; Tandem Mass Spectrometry | 2018 |
Orbital involvement by non-Hodgkin lymphoma NK T cells.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Bone Marrow; Cisplatin; Cytarabine; Ethmoid Sinus; Etoposide; Exophthalmos; Fatal Outcome; Humans; Lymphoma, Extranodal NK-T-Cell; Male; Maxillary Sinus; Methylprednisolone; Nasal Obstruction; Neoplasm Recurrence, Local; Orbit; Salvage Therapy; Tomography, X-Ray Computed | 2014 |
[Successful treatment with high-dose methotrexate/cytarabine regimen in a patient in SMILE regimen-resistant extranodal natural killer/T-cell lymphoma].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Cytarabine; Dexamethasone; Drug Administration Schedule; Drug Resistance, Neoplasm; Etoposide; Humans; Ifosfamide; Lymphoma, Extranodal NK-T-Cell; Male; Methotrexate; Treatment Outcome | 2014 |
Concurrent Etoposide, Steroid, High-dose Ara-C and Platinum chemotherapy with radiation therapy in localised extranodal natural killer (NK)/T-cell lymphoma, nasal type.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; Cranial Irradiation; Cytarabine; Etoposide; Female; Humans; Kaplan-Meier Estimate; Lymphoma, Extranodal NK-T-Cell; Male; Middle Aged; Neoplasm Staging; Nose Neoplasms; Platinum Compounds; Radiation Dosage; Remission Induction; Retrospective Studies; Steroids; Time Factors; Treatment Outcome; Young Adult | 2015 |
Successful Treatment of Genetically Profiled Pediatric Extranodal NK/T-Cell Lymphoma Targeting Oncogenic STAT3 Mutation.
Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Chemoradiotherapy; Child; Cytarabine; Dexamethasone; DNA Mutational Analysis; Etoposide; Female; Humans; Hydrocortisone; Hydroxamic Acids; Ifosfamide; Lymphoma, Extranodal NK-T-Cell; MAP Kinase Kinase 1; Methotrexate; Mutation; Positive Regulatory Domain I-Binding Factor 1; Precision Medicine; Repressor Proteins; STAT3 Transcription Factor; Vorinostat | 2016 |
Sub-acute demyelinating neuropathy associated with an NK/T cell lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Cyclophosphamide; Cytarabine; Demyelinating Diseases; Doxorubicin; Etoposide; Facial Paralysis; Female; Humans; Ifosfamide; Lymphoma, Extranodal NK-T-Cell; Magnetic Resonance Imaging; Methotrexate; Neurologic Examination; Omentum; Paraneoplastic Polyneuropathy; Spinal Nerve Roots; Tomography, X-Ray Computed; Treatment Outcome; Vincristine | 2008 |